Skip to content

Application of Triptorelin Acetate Microspheres for Injection in the long protocol of GnRH-a: A randomized controlled clinical trial

Application of Triptorelin Acetate Microspheres for Injection in the long protocol of GnRH-a: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102851
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Prutiparin Acetate Microsphere for Injection:Triptorelin acetate for injection
Intervention group:Triptorelin Acetate Microspheres for Injection

Sponsors

The first people's Hospital of Yunnan Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1.First IVF cycle entry due to female tubal factors or male factors; 2.Age: 20–38 years; 3.Implementation of the long luteal phase protocol; 4.Normal ovarian reserve function:Baseline E2 1.1 ng/ml (Anti-Müllerian Hormone, used for ovarian function assessment; >1.1 ng/ml indicates good ovarian reserve),AFC (Antral Follicle Count) between 5 and 20.

Exclusion criteria

Exclusion criteria: 1.Presence of contraindications for pregnancy or assisted reproductive technology (ART); 2.Reproductive tract abnormalities affecting pregnancy, such as uterine malformations, severe intrauterine adhesions, advanced adenomyosis, submucosal fibroids compressing the uterine cavity, or large intramural fibroids; 3.Untreated severe endocrine/metabolic disorders, or cardiovascular, cerebrovascular, hepatic, or renal diseases; 4.BMI > 30 kg/m^2; 5.Allergy to ovulation induction drugs.

Design outcomes

Primary

MeasureTime frame
Incidence of premature LH surge;

Secondary

MeasureTime frame
Pituitary down-regulation success rate;Clinical pregnancy rate (fresh cycle);Implantation rate (fresh cycle);Transferable embryo rate (fresh cycle);

Countries

China

Contacts

Public Contactliyunxiu

The first people's Hospital of Yunnan Province

105935559@qq.com+86 871 6363 8247

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026